Acquisition by Michael Grey of 17500 shares of Reneo Pharmaceuticals subject to Rule 16b-3
RPHMDelisted Stock | USD 18.20 1.40 8.33% |
About 55% of RPHM Old's investors are presently thinking to get in. The analysis of current outlook of investing in RPHM Old suggests that some traders are interested regarding RPHM Old's prospects. RPHM Old's investing sentiment overview a quick insight into current market opportunities from investing in RPHM Old. Many technical investors use RPHM Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
RPHM |
Filed transaction by Reneo Pharmaceuticals Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
RPHM Old Fundamental Analysis
We analyze RPHM Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RPHM Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RPHM Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
RPHM Old is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
RPHM Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RPHM Old stock to make a market-neutral strategy. Peer analysis of RPHM Old could also be used in its relative valuation, which is a method of valuing RPHM Old by comparing valuation metrics with similar companies.
Peers
RPHM Old Related Equities
DNA | Ginkgo Bioworks | 6.18 | ||||
LEGN | Legend Biotech | 3.91 | ||||
CCCC | C4 Therapeutics | 2.07 | ||||
CNSP | Cns Pharmaceuticals | 2.00 | ||||
CGEM | Cullinan Oncology | 1.18 | ||||
PRME | Prime Medicine, | 0.70 | ||||
VIR | Vir Biotechnology | 0.60 | ||||
KRON | Kronos Bio | 0.10 | ||||
OCEA | Ocean Biomedical | 0 | ||||
APLS | Apellis Pharmaceuticals | 0.00 | ||||
SMMT | Summit Therapeutics | 0.00 | ||||
HEPA | Hepion Pharmaceuticals | 0.21 | ||||
RPRX | Royalty Pharma | 0.65 | ||||
HOWL | Werewolf Therapeutics | 0.75 | ||||
NKTX | Nkarta | 0.80 | ||||
IMMX | Immix Biopharma | 0.97 | ||||
ADPT | Adaptive Biotechnologies | 1.59 | ||||
EWTX | Edgewise Therapeutics | 1.72 | ||||
KZR | Kezar Life | 2.37 | ||||
CELC | Celcuity LLC | 2.84 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in RPHM Stock
If you are still planning to invest in RPHM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RPHM Old's history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |